Citation Impact
Citing Papers
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
2006
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy
2001
Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial
2006
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer
2007
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer
2004
MRP and MDR1 gene expression in primary breast carcinomas.
1996
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Multidrug Resistance in Breast Cancer: a Meta-analysis of MDR1/gp170 Expression and Its Possible Functional Significance
1997
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer.
1996
A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer
1998
Preoperative Chemotherapy in Operable Breast Cancer
1993
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
1997
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Primary Systemic Treatment with Weekly Doxorubicin Monotherapy in Women with Locally Advanced Breast Cancer; Clinical Experience and Parameters Predicting Outcome
1996
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
The properties of high-dimensional data spaces: implications for exploring gene and protein expression data
2007
Metagenomic biomarker discovery and explanation
2011 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The biology of the P-glycoproteins
1995
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Clinical trials of p-glycoprotein reversal in solid tumours
1996
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
2009 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
2008
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
1998 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological Disorders
2004
Angiogenesis as a therapeutic target
2005 StandoutNature
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Tumor Angiogenesis
2008 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival
2003
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial.
1994
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation
2013 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Tumour stem cells and drug resistance
2005 Standout
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
2004
Modulation of doxorubicin resistance in multidrug‐resistant cells by liposomes
1993
Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
1998
Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
2000
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm
2003
Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein
2003
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels
1998 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of V. Feillel being referenced
Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome
2003
Clinical and pathological response to primary chemotherapy in operable breast cancer
1997
Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
2002
Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma
1991
Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis
1993
Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy
2002
Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression
2002
Neoadjuvant chemotherapy in 126 operable breast cancers☆
1992